Details for Patent: 4,839,350

Summary for Patent: 4,839,350

Title:	Cephalosporin compounds and the production thereof
Abstract:	A class of new caphalosporin compounds (syn-isomer) is now provided, which is useful as antibacterial agent and is represented by the general formula (I) ##STR1## wherein R.sup.1 is an amino group or a protected amino group; R.sup.2 is a lower alkyl group, a carboxymethyl group or a protected carboxymethyl group; R.sup.3 is a hydrogen atom, a salt-forming cation or a carboxyl-protecting group; A is an unsubstituted or substituted phenyl group, an unsubstituted or substituted furyl group, an unsubstituted or substituted thiazolyl group or an unsubstituted or substituted 3-lower-alkylthiazolio group, and a pharmaceutically acceptable salt or ester thereof.
Inventor(s):	Atsumi; Kunio (Kawasaki, JP), Sakagami; Kenji (Kawasaki, JP), Yamamoto; Yuichi (Yokohama, JP), Yoshida; Takashi (Tokyo, JP), Nishihata; Ken (Yokohama, JP), Kondo; Shinichi (Yokohama, JP), Fukatsu; Shunzo (Tokyo, JP)
Assignee:	Meiji Seika Kaisha, Ltd. (Tokyo, JP) Susumu Mitsuhashi (Tokyo, JP)
Application Number:	07/036,124
Patent Claim Types: see list of patent claims	Compound; Composition;

Drugs Protected by US Patent 4,839,350

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

Foreign Priority and PCT Information for Patent: 4,839,350

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Japan	59-186464	Sep 07, 1984
Japan	60-157005	Jul 18, 1985

International Family Members for US Patent 4,839,350

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	56017
Canada	1272714
China	1034940
China	85106733
Germany	3579399
European Patent Office	0175610
Spain	546749